亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

河南領先科技藥業有限公司  

高純度的原料藥,像樟腦磺酸鈉,氯化銨甲酰甲膽堿(比賽可靈,氯鋇膽堿),乙酰甲喹(痢菌凈),三氮脒(貝尼爾,血蟲凈),甲磺酸培氟沙星,喹烯酮,頭孢噻呋,硫酸阿托品,布他磷……

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李清虎
  • 電話:0371-86670588
  • 郵件:lxyyy888@sina.com
  • 傳真:0371-86670600
  • QQ:2691378018
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 供應高純度的甲磺酸培氟沙星
供應高純度的甲磺酸培氟沙星
單價 面議對比
詢價 暫無
發貨 河南許昌市付款后3天內
庫存 100000000千克起訂25千克
品牌 甲磺酸培氟沙星
型號 70458-92-3
規格 ≥99.0%
過期 長期有效
更新 2015-10-06 16:21
 
詳細信息

   

甲磺酸培氟沙星

C A S 】70458-92-3
【化 學 名】1-乙基-6-氟-1,4-二氫-7-(4-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸甲磺酸鹽
【分子式與分子量】C17H20FN3O3·CH4O3S·2H2O=465.49
【純   度】≥99.0%
【性   狀】本品為白色或微黃色的結晶性粉末;無臭,味苦。本品在水中極易溶解,在乙醇中極微溶解,在氯仿中幾乎不溶
【標   準】農業部《獸藥質量標準》
【包裝規格】25kg/桶(Φ380mmH480mm)

        作用與用途:抗菌藥,用于畜禽細菌及支原體感染

©2025 河南領先科技藥業有限公司 版權所有   技術支持:化工網   訪問量:11330  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |